U.S. Life Sciences Stock News

NasdaqCM:PGY
NasdaqCM:PGYSoftware

July 2026's Leading Growth Companies With Insider Ownership

Over the last 7 days, the United States market has experienced a slight dip of 1.4%, yet it has shown resilience with a notable 17% rise over the past year, and earnings are projected to grow by 18% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests amidst fluctuating market conditions.
NasdaqGS:KNDI
NasdaqGS:KNDIAuto Components

Spotlight On MoneyHero And 2 Promising Penny Stocks

Over the last 7 days, the United States market has dropped 1.4%, though it has risen by 17% over the past year, with earnings expected to grow by 18% per annum in coming years. In light of these conditions, identifying stocks that combine strong financials with growth potential is crucial for investors seeking value. Penny stocks, while an outdated term, still represent smaller or less-established companies that can offer significant opportunities; we've identified three such stocks that...
NYSE:KLAR
NYSE:KLARDiversified Financial

AI Infrastructure Stocks Backed By Insider Ownership Investors May Want To Watch

With inflation, energy costs and interest rate expectations all in focus, many investors are looking for growth stories where management is strongly aligned with shareholders. Fast growing stocks with high insider ownership can fit that brief because executives and founders have more at stake alongside you. This screener highlights companies where analysts and management share an optimistic view on future prospects, while insiders hold a meaningful slice of the shares. In this article you...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Sanmina (SANM) Nears Earnings With A Pullback, Is The 10% Discount Enough?

Sanmina (SANM) heads into its July 27 earnings report with Wall Street expecting higher year over year earnings and revenue for the June 2026 quarter, even as a negative Earnings ESP tempers expectations. See our latest analysis for Sanmina. Sanmina’s share price has pulled back over the past month, with a 30 day share price return of down 16.4%. Momentum over longer horizons remains strong, highlighted by a year to date share price return of 26.7% and a five year total shareholder return of...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Is Stagwell (STGW) Undervalued On Curate Launch Or Is Growth Already Priced In?

Stagwell (STGW) is drawing fresh attention after unveiling Curate, a centralized marketplace for premium ad inventory across CTV, online video, display and audio, designed to cut out traditional ad-tech intermediaries. See our latest analysis for Stagwell. Stagwell’s launch of Curate comes after a strong year-to-date share price return of 56.66%. However, short term momentum has cooled, with the 7 day share price return down 5.85% and the 1 day move down 1.33%. If you are comparing Stagwell...
NYSE:FERG
NYSE:FERGTrade Distributors

Is Ferguson Enterprises (FERG) Undervalued As Its LSE Delisting Reshapes Investor Access?

Ferguson Enterprises stock and the LSE delisting event Ferguson Enterprises (FERG) has completed the cancellation of its secondary London Stock Exchange listing and has kept its primary listing on the New York Stock Exchange. This is a structural change that may influence how some investors access and trade the stock. See our latest analysis for Ferguson Enterprises. In the months leading up to the LSE delisting, Ferguson Enterprises’ share price has eased, with a 30-day share price return...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

What Hillman Solutions (HLMN)'s Debt Maturity Extension and 2026 Guidance Means For Shareholders

In July 2026, Hillman Solutions Corp. launched a refinancing of its existing Term Loan B and asset-based revolving credit facility, proposing a US$735 million senior secured Term Loan B maturing in 2033 and a US$375 million senior secured asset-based revolver maturing in 2031 to replace nearer-term facilities and fund general corporate purposes. At the same time, Hillman issued second-quarter 2026 and full-year 2026 guidance pointing to higher net sales and operating income, highlighting how...
NYSE:WAL
NYSE:WALBanks

Do Western Alliance’s Q2 Results Reshape Confidence in Its Revenue Story and Risk Profile (WAL)?

Western Alliance Bancorporation reported its Q2 2026 results on July 21 after the market close, following a prior quarter where revenue surpassed expectations but earnings per share fell short. This latest earnings release comes after analysts reaffirmed forecasts calling for strong year-on-year revenue growth, underscoring continued confidence in the bank’s operating trajectory despite earlier earnings volatility. Now we’ll examine how these pre-earnings expectations for solid revenue...
NYSE:BNL
NYSE:BNLREITs

Broadstone Net Lease (BNL) Lands A Colorado Facility Deal, Is The Stock Fully Priced?

Why This New Colorado Project Matters For Broadstone Net Lease Stock Broadstone Net Lease (BNL) has drawn fresh attention after entering a joint venture to develop a 112,000 square foot advanced technology facility in Colorado, supported by an estimated US$303 million investment. The project features a triple-net lease with a 15-year initial term, two 5-year extension options and 3% annual rent increases, with projected cash yields of 8.5% in year one and 9.7% in year two. See our latest...
NYSE:W
NYSE:WSpecialty Retail

Is Wayfair (W) Fairly Valued Following Its Recent Efficiency Screen Spotlight?

Wayfair (W) features in a recent screen of companies that scored well on key efficiency ratios, prompting fresh attention to how its business performance lines up with the current share price near US$87.76. See our latest analysis for Wayfair. Over the past year, Wayfair has combined a strong 1 year total shareholder return of 55.55% with periods of share price volatility, including a 9.60% 90 day share price return and a decline of 17.64% year to date. This suggests momentum has cooled...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

How Investors Are Reacting To Sabra Health Care REIT (SBRA) Re-Tenanting Avamere Portfolio To Boost Cash NOI

Earlier in July 2026, Sabra Health Care REIT, Inc. reported a business update outlining the re-tenanting of 26 Avamere-leased properties, mostly to Cascadia Healthcare subsidiaries, alongside portfolio moves expected to lift annualized cash NOI by over US$9.00 million and an increase to its full-year 2026 guidance. The planned transition, which Sabra expects to boost annualized cash rent by nearly 30%, highlights how operator changes and asset repositioning can materially reshape the REIT’s...
NYSE:DMC
NYSE:DMCFood

Is Del Monte’s Larger Credit Line Quietly Reframing Its Capital Allocation Story (DMC)?

Earlier this month, Del Monte Corporation amended its senior unsecured revolving credit facility, lifting total commitments by US$150 million to US$900 million while maintaining the February 21, 2029 maturity and substantially similar terms, keeping the facility unsecured and available for general corporate purposes. This expanded credit capacity gives Del Monte additional financial flexibility as it integrates a recent acquisition and funds seasonal working capital needs, potentially...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

3 Cash Flow Stocks Backed By AI Infrastructure And Defense Demand

With inflation worries, shifting central bank expectations and energy costs in focus, many investors are looking for solid cash generators that are not yet fully reflected in their share prices. The Undervalued Stocks Based On Cash Flows screener targets companies where SWS DCF valuation suggests the market price sits below estimated fair value, which can appeal if you care about cash flows and valuation discipline. In this article, you will see 3 of the stocks flagged by this cash flow...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron (MU) Stock Still Looks Cheap After Its $250b US Push

Micron Technology stock has delivered a very large 3 year return, and the latest valuation checks and recent pullback raise the question of how much of that story is already in the price. Micron has returned about 12x over the past 3 years, which puts extra focus on whether current buyers are paying up for past gains. Heavy investment in AI focused memory capacity and U.S. manufacturing can support long term earnings power, while rising competition from new DRAM players and sector wide...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

US Semiconductor Stocks For Tariff Driven AI Infrastructure Demand

New US tariffs on major trading partners and a proposed 100% levy on imported semiconductors are reshaping the risk and reward profile for chip investors almost overnight. Higher import costs, potential trade friction, and shifting supply chains are pushing attention toward US Domestic Semiconductor Manufacturers that design and build more inside US borders. This article explains how that tariff shock may affect the sector and highlights 3 US semiconductor stocks from the screener that appear...
NYSE:MHO
NYSE:MHOConsumer Durables

3 Homebuilder Stocks That Could Gain As Institutional Landlords Pull Back

Institutional landlords are being forced to hit pause on buying single family rentals just as new housing rules push them to sell inventory, cut prices, and rethink their business models. For individual investors, that shift can change where capital flows next, especially towards companies linked to homebuilding and build to rent development. This article explains how that policy change and the increase in institutional listings could affect publicly traded housing related stocks, and...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Should FDA Priority Review of Dyne’s DMD Drug Candidate Reshape Risk Expectations for Dyne Therapeutics (DYN) Investors?

Dyne Therapeutics, Inc. recently reported that the U.S. FDA accepted for review its biologics license application for zeleciment rostudirsen (z-rostudirsen, DYNE-251) to treat Duchenne muscular dystrophy patients amenable to exon 51 skipping, granting Priority Review with a target action date of January 21, 2027. The BLA filing is backed by DELIVER trial data showing statistically significant dystrophin increases, functional gains and a favorable safety profile, making z-rostudirsen a key...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Could Be 57% Undervalued As Leadership Change Draws Focus

Fiserv (FISV) is back in focus after President Dhivya Suryadevara resigned for good reason, with long-time executives Andrew Gelb and Srini Krish stepping in as interim leaders of the Financial Solutions business. See our latest analysis for Fiserv. Fiserv's recent executive shake-up comes after a mixed run in the stock, with a 1-month share price return of 7.98% but a year to date share price return that is down 21.21%, and a 1-year total shareholder return that has declined 68.77%. This...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Holdings (ZBH) Could Be 9% Undervalued After Asia Pacific Leadership Change

Zimmer Biomet Holdings (ZBH) has drawn fresh attention after appointing Chintan Desai as president of its Asia Pacific Region, marking a key leadership transition following Sang Yi’s planned departure in August 2026. See our latest analysis for Zimmer Biomet Holdings. Zimmer Biomet Holdings’ recent leadership change in Asia Pacific comes as the stock trades at US$89.72, with a 30-day share price return of 1.99% but a 1-year total shareholder return that has declined 2.08%. This suggests short...
NasdaqGS:GABC
NasdaqGS:GABCBanks

Will Anticipated Earnings Beat on Higher Revenue Change German American Bancorp's (GABC) Narrative

German American Bancorp recently drew attention as analysts highlighted an expected year-over-year earnings increase on higher revenues ahead of its upcoming quarterly report. The company’s positive Earnings ESP of 0.54% combined with a Zacks Rank of 3 has strengthened expectations that it could outperform consensus EPS estimates. We’ll now examine how this potential earnings beat, underpinned by higher anticipated revenues, shapes German American Bancorp’s broader investment narrative. Find...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

How Renewed Earnings Optimism Will Impact Sirius XM Holdings (SIRI) Investors

In recent days, investors have become more optimistic about Sirius XM Holdings ahead of its upcoming quarterly earnings release, as the company has a track record of exceeding earnings expectations and is currently showing indicators that point to a possible earnings beat. This pattern of outperforming analyst estimates is drawing attention because it reinforces confidence in the company’s ability to manage costs and monetize its audio platform effectively. Now, we’ll consider how this...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest (ARCB) Is Up 5.8% After Restructuring, Brand Consolidation And Impairment Charges - Has The Bull Case Changed?

On July 16, 2026, ArcBest Corporation announced a restructuring plan that includes a roughly 2% workforce reduction, brand consolidation under the ArcBest name, ten ABF Freight service center closures, discontinuation of the Vaux Freight Movement System, and an estimated US$6.0 million–US$7.0 million in cash charges plus about US$76.5 million in non-cash impairments. An interesting angle is that despite these sizable write-offs, such as fully impairing the Panther trade name and Vaux Freight...
NasdaqGS:LI
NasdaqGS:LIAuto

Is Li Auto’s New Mass‑Market L6 SUV Redefining the Investment Case For Li Auto (LI)?

Li Auto has already launched the new Li L6, an all-wheel drive SUV priced at RMB 249,800 for the standard configuration, with deliveries beginning within a week of the July 16, 2026 announcement. This launch adds a fresh model to Li Auto’s SUV lineup, potentially broadening its appeal among mid-range family buyers and enriching its product mix. We’ll now explore how the Li L6’s launch timing and mass-market positioning may influence Li Auto’s existing investment narrative. Outshine the...